GeneralWIREDFernanda González
New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
At a glance
The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
- Primary source
- WIRED — Read original article
- Published
- Topic
- General
The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
This summary comes from WIRED. Read the full article at the original source.